Skip to main content

Table 1 Characteristics of studies that reported the relationship between vitamin D3 status and childhood infectious diarrhea

From: Vitamin D3 supplementation as an adjunct in the management of childhood infectious diarrhea: a systematic review

Study (first author’s name and year of publication)

Country of study

Study setting

Study population (sample size and age/sex distribution)

Study design

Aluisio et al. [17], 2013

Afghanistan

Five inner-city districts of Kabul/Passive surveillance center at Maiwind Teaching Hospital

-N = 3046

-1-11 months

-Equal M/F distribution

Double-blind, placebo-controlled, randomized trial

Thornton et al. [23], 2013

Colombia

Hospital-based setting in Bogotá

-N = 475

-Mean (± SD) age: 8.9 ± 1.6 years

Longitudinal/Prospective study

Mileva et al. [15], 2014

Bulgaria

Department of Infectious Diseases, Medical University of Varna

-N = 77 (n = 30, group A patients† & n = 47, group B patients‡)

-12-42 months

Cohort study

Talachian et al. [22], 2015

Iran

Department of Pediatrics, Hazrat-e-Rasoul Akram Hospital, Tehran

-N = 50 (n = 25 with acute infectious diarrhea & n = 25 as controls)

-6 months-15 years

-Mean (± SD) age: 25.9 ± 25.6 months

M/F ratio: 1.7:1 * & 1.5:1 §

Cross-sectional study

Bucak et al. [25], 2016

Turkey

Department of Pediatrics, Adıyaman University School of Medicine, Adıyaman

-N = 137 (n = 70 with rotaviral diarrhea & n = 67 as healthy controls)

-1-5 years

Cross-sectional study

Ahmed et al. [26], 2016

Bangladesh

Community-based setting in the urban community of Mirpur, Dhaka

-N = 912 (n = 446 normal-weight children & n = 466 underweight children)

-6-24 months

Cohort study

Palframan et al. [24], 2018

Colombia

Community-based setting in the context of Bogotá School Children Cohort

-N = 540

-Mean ± SD age: 8 ± 1.6 years

-M/F:48%/52%

Longitudinal study

Mahyar et al. [16], 2019

Iran

Qazvin Children Hospital, affiliated with Qazvin University of Medical Sciences (Qazvin, Iran)

-N = 120 (n = 60 with acute bacterial diarrhea & n = 60 as controls)

-2 months-12 years

-M/F: 63.3%/36.7% * & 51.6%/48.4%§

Cross-sectional study

Hassam et al. [21], 2019

Tanzania

Muhimbili National hospital, Dar es Salaam

-N = 188 under-five children (n = 47, cases n = 94, sick controls & n = 47, healthy controls)

-Mean ± SD age: 17.01 ± 14.8 months

-M/F: 70.2%/29.8% * & 53.2%/46.8%§

Unmatched case-control study

  1. M, male F, female SD, standard deviation * Case group §Control group †Patients with risk factors for severe diarrhea ‡Patients without risk factors for severe diarrhea